A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: A North Central Cancer Treatment Group trial

Gerardo Colon-Otero, Robert D. Niedringhaus, Shauna H. Hillman, Susan Geyer, Jeffrey Sloan, James E. Krook, Harold E. Windschitl, Randolph S. Marks, Martin Wiesenfeld, Loren K. Tschetter, James J. Jett

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: A North Central Cancer Treatment Group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences